Bright Minds Biosciences Inc. Share Price
Equities
DRUG
CA10919W4056
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.29 CAD | -0.77% | -21.82% | -39.15% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 8.11M 11.17M 677M |
---|---|---|---|---|---|
Net income 2022 | -15M -20.66M -1.25B | Net income 2023 | -7M -9.64M -584M | EV / Sales 2022 | - |
Net cash position 2022 | 11.49M 15.82M 959M | Net cash position 2023 | 6.67M 9.19M 557M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.4
x | P/E ratio 2023 |
-1.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 63.85% |
1 day | -0.77% | ||
1 week | -21.82% | ||
Current month | -12.84% | ||
1 month | -21.82% | ||
3 months | -54.74% | ||
6 months | -30.27% | ||
Current year | -39.15% |
Managers | Title | Age | Since |
---|---|---|---|
Ian McDonald
FOU | Founder | 37 | 31/19/31 |
Ryan Cheung
DFI | Director of Finance/CFO | 45 | 29/20/29 |
Jan Pedersen
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian McDonald
FOU | Founder | 37 | 31/19/31 |
David Weiner
BRD | Director/Board Member | 59 | 17/23/17 |
Jeremy Fryzuk
BRD | Director/Board Member | 39 | 29/20/29 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 1.3 | -11.56% | 23,500 |
26/24/26 | 1.47 | -10.91% | 100 |
Delayed Quote Canadian Securities Exchange, April 01, 2024 at 12:41 am IST
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.15% | 4.22M | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- DRUG Stock